PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis-MedSci.cn

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

Garcia-Gonzalez, J; Ruiz-Banobre, J; Afonso-Afonso, FJ; Amenedo-Gancedo, M; Areses-Manrique, MD; Campos-Balea, B; Casal-Rubio, J; Fernandez-Nunez, N; Perez, JLF; Lazaro-Quintela, M; Parente, DP; Crama, L; Ruiz-Gracia, P; Santome-Couto, L; Leon-Mateos, L

Garcia-Gonzalez, J; Ruiz-Banobre, J; Leon-Mateos, L (corresponding author), CIBERONC, Dept Med Oncol, Univ Clin Hosp Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela 15706, Spain.; Garcia-Gonzalez, J; Ruiz-Banobre, J; Leon-Mateos, L (corresponding author), CIBERONC, Translat Med Oncol Grp Oncomet, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela 15706, Spain.

Abstract

The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeuti......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

科室

工具

服务